Fennec Pharmaceuticals Inc. · NASDAQ:FENC
Hackman Jeffrey S. received 2,224 Fennec Pharmaceuticals Inc. shares as an award (Form 4)
Traded Oct 12, 2026 · Filed Oct 13, 2026
On Oct 12, 2026, Hackman Jeffrey S. (Director, Chief Executive Officer) received 2,224 Fennec Pharmaceuticals Inc. shares as an award at US$5.53 for US$12,299, leaving 69,685 shares. Filed Oct 13, 2026 (Form 4).
- Awarded
- 2,224 shares
- Price
- US$5.53
- Value
- US$12,299
- Holding after
- 69,685 shares
- Trading plan
- No
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 12, 2026 | Common Shares | Award | 2,224 | US$5.53 | 69,685 | Direct |
Source
Related
- Fennec Pharmaceuticals Inc.
- Hackman Jeffrey S.
- Fennec Pharmaceuticals Inc. shareholders
- Form 4 · Hackman Jeffrey S. · Oct 1, 2026
- Form 4 · Hackman Jeffrey S. · Aug 31, 2026
- Form 4 · Hackman Jeffrey S. · Aug 3, 2026
- Form 4 · Hackman Jeffrey S. · Jul 1, 2026
- Form 4 · Hackman Jeffrey S. · Jun 1, 2026
- Schedule 13G/A · Orin Hirschman · Oct 19, 2026
- Form 4 · Andrade Robert · Oct 13, 2026
- Form 4 · Cioffi Christiana Marie · Oct 13, 2026
- Form 4 · Evans Terry L · Oct 13, 2026
- Form 4 · Sayad Pierre Sargis · Oct 13, 2026